Thomas Peter Kalmbach

EVP & CFO Thomas Peter Kalmbach sold 7,936 shares of GL at $156.59 on 2026-05-22, reducing holdings to 50,495 shares; 5 prior GL sells all posted negative 90d returns.

On 2026-05-22, Thomas Peter Kalmbach (EVP & CFO) sold 7,936 shares at $156.59, reducing his holdings by -13.6% to 50,495 shares. The stock is trading near its 52-week high of $157.92 at current price $156.70, up 8.7% over 90 days. Notably, across Kalmbach's 5 prior sales at GL, all posted negative 90-day returns (ranging from -1.4% to -2.8%), with a 90-day well-timed rate of 100% at this ticker. His cross-ticker track record on 8 prior sells shows an average 90-day return of -3.2% with a 100% well-timed rate. The company has solid fundamentals: $1.6B in latest-quarter revenue, $270.5M net income, and a P/E of 10.34. The question for investors is whether this sale—given the consistent negative post-sale price movements in Kalmbach's prior GL transactions—represents another instance of the pattern, or a break from it in a market that has recently rallied.

CFO Kalmbach sold 11,903 shares of GL at $156.61 for $1.9M; 5 of 5 prior GL sales were well-timed with negative 90d returns.

Thomas Peter Kalmbach, EVP & CFO, sold 11,903 shares at $156.61 on 2026-05-19, reducing his holdings by 19.7% from 60,334 to 48,431 shares. His prior trading pattern at GL is notable: all 5 previous sales were well-timed at the 90-day mark, each followed by stock declines ranging from -1.4% to -2.8% over 90 days. The current sale price of $156.61 is -2.4% from the 52-week high of $157.92, placing it near but slightly below recent peaks. GL trades at a P/E of 10.16 with $1.6B in latest quarterly revenue and a $12.0B market cap, fundamentals that provide context for evaluating the signal. Investors should monitor whether this sale follows the established pattern of his prior GL trades or represents a departure from his timing accuracy at this ticker.

Globe Life CFO Kalmbach acquires 35,000 shares net while selling 27,427; mixed-timing insider with strong 90-day track record but conflicting short-term signals.

Kalmbach, the company's Chief Financial Officer, executed a complex two-day set of transactions on May 8–11 that netted an acquisition of 35,000 shares, making this his first open-market purchase in the three-year filing window. The trade is notable because it occurs in a company with solid fundamentals—profitable with modest revenue growth—and the stock trades very near its 52-week high. Kalmbach's prior trading record at this ticker is mixed: his four earlier sales have all proven well-timed as the stock declined after each exit, yet his one prior purchase showed poor timing with shares falling in the following month before recovering over a longer period. The current transaction's unusual structure—simultaneous buying and selling across two days—suggests active rebalancing rather than conviction-based accumulation, and the fact that he sold nearly as many shares as he acquired complicates the bullish signal that a pure acquisition might otherwise send.

Globe Life CFO Kalmbach sells 28,952 shares ($4.1M) across 4 trades at $139.79–$142.67

Kalmbach Thomas Peter, EVP & CFO of Globe Life Inc., executed 4 separate sales on 2025-07-29 totaling 28,952 shares for $4,081,484.98 at a blended average price of $140.97, reducing his holdings by 48.6% from 59,617 to 30,665 shares. The sales occurred near the 52-week high of $143.27 (-2.0% from peak), during a period when the stock has risen 12.5% over 30 days and 15.3% over 90 days. Across Kalmbach's cross-ticker track record, his prior buy at Globe Life in May 2024 generated a 90-day return of +13.7%, and his overall open-market history shows a 100% win rate on 90-day returns. The coincidence of a substantial, multi-transaction divestiture at historically elevated valuations—following a sustained rally and in proximity to the stock's recent range ceiling—merits attention to any material developments or strategic capital allocation announcements from the company.